Literature DB >> 4614864

[Kinetic study of 2 beta lactamases responsible for the same phenotype].

R Labia, F Le Goffic, J Andrillon.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4614864     DOI: 10.1016/s0300-9084(74)80092-1

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


× No keyword cloud information.
  7 in total

1.  Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae.

Authors:  C Mabilat; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

2.  Types of beta-lactamase determined by plasmids in gram-negative bacteria.

Authors:  M Matthew; R W Hedges; J T Smith
Journal:  J Bacteriol       Date:  1979-06       Impact factor: 3.490

3.  Molecular hybridization versus isoelectric focusing to determine TEM-type beta-lactamases in gram-negative bacteria.

Authors:  M Jouvenot; M L Deschaseaux; M Royez; C Mougin; R C Cooksey; Y Michel-Briand; G L Adessi
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

4.  Evolution of plasmid-coded resistance to broad-spectrum cephalosporins.

Authors:  C Kliebe; B A Nies; J F Meyer; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

5.  Beta-lactamases produced by a Pseudomonas aeruginosa strain highly resistant to carbenicillin.

Authors:  R Labia; M Guionie; J M Masson; A Philippon; M Barthelemy
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

6.  Beta-lactamases: determination of their isoelectric points.

Authors:  M Barthelemy; M Guionie; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

7.  HR 756, the syn isomer of a new methoxyimino cephalosporin with unusual antibacterial activity.

Authors:  Y A Chabbert; A J Lutz
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.